These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14596690)

  • 21. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.
    Winterhalder R; Deschler-Marini S; Landmann C; Kann R; Passweg J; Herrmann R; Pless M
    Radiother Oncol; 2004 Dec; 73(3):321-4. PubMed ID: 15588877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemotherapy for lung cancer].
    Kurata T; Fukuoka M
    Nihon Rinsho; 2002 May; 60 Suppl 5():309-16. PubMed ID: 12101679
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer].
    Goldobenko GV; Kanaev SV
    Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neoadjuvant chemoradiotherapy and peroperative radiotherapy for non-small-cell lung cancer of the apex. A study of 5 cases].
    Vincent L; Guibert B; Mornex F; Grangeon V; Harf R; Gormand F; Pacheco Y
    Rev Pneumol Clin; 2001 Sep; 57(4):271-7. PubMed ID: 11593153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
    J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract]   [Full Text] [Related]  

  • 29. Palliative thoracic radiotherapy for lung cancer.
    Kepka L; Olszyna-Serementa M
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):559-69. PubMed ID: 20397921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
    Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P
    Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
    Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy in stage III non-small cell lung cancer.
    Eberhardt WE; Hepp R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 34. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
    J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
    Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
    Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel poliglumex/carboplatin is similar to paclitaxel/carboplatin as first-line treatment in elderly patients with advanced non-small-cell lung cancer and a poor performance status.
    Reddy GK
    Clin Lung Cancer; 2005 Jul; 7(1):20-2. PubMed ID: 16098240
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of non-small-cell lung cancer in older persons.
    Basche M; Kelly K
    Oncology (Williston Park); 2003 Jan; 17(1):31-9; discussion 43-4, 47-8. PubMed ID: 12599930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy for non-small cell lung cancer (NSCLC).
    Choy H; Chakravarthy A; Kim JS
    Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985
    [No Abstract]   [Full Text] [Related]  

  • 39. Landmark study shows chemotherapy improves survival in late-stage lung cancer patients.
    Oncology (Williston Park); 2000 Aug; 14(8):1154, 1176. PubMed ID: 10989826
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined-modality therapy in the nonsurgical management of unresectable stage III non-small cell lung cancer.
    Hensing TA; Socinski MA
    Curr Opin Pulm Med; 1999 Jul; 5(4):194-200. PubMed ID: 10407686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.